FDA Inspection
BeiGene, USA Inc.BeiGene, USA Inc. – FDA Inspection, Nov 13, 2023
Record Details
This FDA Inspection record concerns BeiGene, USA Inc., with an inspection on November 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3df9d586-21ad-48a7-8ec6-30d31fd1cafd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222671
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.